In honor of Tatyana Andronova’s 85th anniversary

August 26, 2024, marked the 85th birthday of Tatyana Mikhailovna Andronova, a prominent chemist, Cand. Sci. (Chemistry), the founder and head of the pharmaceutical company Pepteck. Her career is inseparable from the Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, where she has worked for over 50 years, rising from laboratory assistant to lead developer.

Andronova is a worthy successor to her family: her father, M.A. Andronov, was a renowned chemist who developed a method for extracting the amino acid L-arginine. Her key achievement was the method to synthesize glucosaminylmuramyl dipeptide, which she developed in 1976. This enabled industrial-scale production of the highly effective immunomodulator Likopid®, which has been successfully used in clinical practice for almost three decades. Andronova was awarded the Russian Federation Government Award for her contribution to the organization of biotechnological production.

This article highlights Andronova’s numerous scientific and industrial achievements, emphasizing the unbroken scientific dynasty, current scientific developments supervised by her, and her contribution to Russian pharmaceutics.